MX2023006126A - Produccion de arn. - Google Patents

Produccion de arn.

Info

Publication number
MX2023006126A
MX2023006126A MX2023006126A MX2023006126A MX2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A
Authority
MX
Mexico
Prior art keywords
rna
rna manufacturing
manufacturing
dsrna
double
Prior art date
Application number
MX2023006126A
Other languages
English (en)
Spanish (es)
Inventor
Stephanie Fesser
Andreas Kuhn
Thomas Ziegenhals
Original Assignee
BioNTech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNTech SE filed Critical BioNTech SE
Publication of MX2023006126A publication Critical patent/MX2023006126A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2023006126A 2020-12-09 2021-12-07 Produccion de arn. MX2023006126A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063123465P 2020-12-09 2020-12-09
US202063132473P 2020-12-30 2020-12-30
PCT/EP2021/084488 WO2022122689A1 (en) 2020-12-09 2021-12-07 Rna manufacturing

Publications (1)

Publication Number Publication Date
MX2023006126A true MX2023006126A (es) 2023-07-28

Family

ID=79287682

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023006126A MX2023006126A (es) 2020-12-09 2021-12-07 Produccion de arn.

Country Status (10)

Country Link
US (1) US20240110214A1 (cg-RX-API-DMAC7.html)
EP (1) EP4259161A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023552468A (cg-RX-API-DMAC7.html)
KR (1) KR20230129432A (cg-RX-API-DMAC7.html)
AU (1) AU2021395736A1 (cg-RX-API-DMAC7.html)
CA (1) CA3201552A1 (cg-RX-API-DMAC7.html)
IL (1) IL303457A (cg-RX-API-DMAC7.html)
MX (1) MX2023006126A (cg-RX-API-DMAC7.html)
TW (1) TW202237844A (cg-RX-API-DMAC7.html)
WO (1) WO2022122689A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
AU2021461416A1 (en) 2021-08-24 2024-02-22 BioNTech SE In vitro transcription technologies
WO2024163689A1 (en) * 2023-02-01 2024-08-08 Genscript Usa Inc. In vitro transcription methods and compounds for use therein
EP4705499A1 (en) * 2023-05-05 2026-03-11 TriLink BioTechnologies, LLC In vitro transcription method
WO2025170909A1 (en) * 2024-02-05 2025-08-14 The Broad Institute, Inc. Nucleic acids with region-specific modifications and methods of making the same
WO2025223684A1 (en) * 2024-04-23 2025-10-30 BioNTech SE Methods and compositions for stimulating immune response
US20260185136A1 (en) 2024-12-27 2026-07-02 Eisai R&D Management Co., Ltd. 5'-cap modifications of rna

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008626A1 (en) 1993-09-20 1995-03-30 The Regents Of The University Of Colorado Strategy for the production of rna from immobilized templates
US7074596B2 (en) 2002-03-25 2006-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse mRNA cap analogues
EP2049665A2 (en) 2006-07-28 2009-04-22 Applera Corporation Dinucleotide mrna cap analogs
US8153773B2 (en) 2007-06-19 2012-04-10 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap
PL215513B1 (pl) 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
DE102008061522A1 (de) 2008-12-10 2010-06-17 Biontech Ag Verwendung von Flt3-Ligand zur Verstärkung von Immunreaktionen bei RNA-Immunisierung
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
EP2857499A1 (en) 2010-10-01 2015-04-08 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
WO2013059475A1 (en) 2011-10-18 2013-04-25 Life Technologies Corporation Alkynyl-derivatized cap analogs, preparation and uses thereof
SG11201608605QA (en) 2014-06-10 2016-12-29 Curevac Ag Methods and means for enhancing rna production
WO2016005004A1 (en) 2014-07-11 2016-01-14 Biontech Rna Pharmaceuticals Gmbh Stabilization of poly(a) sequence encoding dna sequences
DK4276189T3 (da) 2015-09-21 2026-05-26 Trilink Biotechnologies Llc Initierende oligonukleotidprimere med kappe til syntesering af 5'-ende RNA'er med kappe
WO2017059902A1 (en) 2015-10-07 2017-04-13 Biontech Rna Pharmaceuticals Gmbh 3' utr sequences for stabilization of rna
EP3402881B1 (en) 2016-01-13 2021-04-28 New England Biolabs, Inc. Thermostable variants of t7 rna polymerase
US10337051B2 (en) * 2016-06-16 2019-07-02 The Regents Of The University Of California Methods and compositions for detecting a target RNA
WO2018081318A1 (en) 2016-10-25 2018-05-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion coronavirus spike proteins and their use

Also Published As

Publication number Publication date
AU2021395736A9 (en) 2024-05-16
CA3201552A1 (en) 2022-06-16
TW202237844A (zh) 2022-10-01
KR20230129432A (ko) 2023-09-08
IL303457A (en) 2023-08-01
EP4259161A1 (en) 2023-10-18
WO2022122689A1 (en) 2022-06-16
JP2023552468A (ja) 2023-12-15
US20240110214A1 (en) 2024-04-04
AU2021395736A1 (en) 2023-07-27

Similar Documents

Publication Publication Date Title
PH12019501457A1 (en) Compositions and methods for treating alpha-1 antitrypsin deficiency
PH12021550686A1 (en) Compositions and methods for lactate dehydrogenase (ldha) gene editing
WO2018146557A3 (en) Long double-stranded rna for rna interference
AU2018323509A1 (en) Method and system for characterization for female reproductive system-related conditions associated with microorganisms
WO2019068011A3 (en) Genetic knockouts in wood-ljungdahl microorganisms
WO2021163654A8 (en) Rnas for complement inhibition
EP4529777A3 (en) Allulose syrups
MY143994A (en) Aerated food products and methods for producing them
MX2022009658A (es) Composiciones y metodos para la edicion de genes de calicreina (klkb1).
MY193225A (en) Methods for continuous production of products from microorganisms
MX2023002960A (es) Tecnologia de proceso para fabricacion de productos biologicos y purificacion aguas abajo.
MX2022010793A (es) Metodos para refinacion de licores fuertes.
PH12021500009A1 (en) Rna molecules comprising non-canonical base pairs
MY204032A (en) Sugar reduced products and method of producing thereof
CA3019753C (en) Cell culture process
WO2019079656A8 (en) Selective enrichment of a population of dna in a mixed dna sample through targeted suppression of dna amplification
MY191789A (en) Production of glycolaldehyde by thermolytic fragmentation
WO2021146654A8 (en) Silk coated leather and products and methods of preparing the same
EP4685234A3 (en) Proteases for beer haze reduction
WO2019071052A3 (en) Production of polyhydroxybutyrate in wood-ljungdahl microorganisms
GB202216606D0 (en) Methods, uses and products
EP4304849A4 (en) COMPOSITES, SYSTEMS AND METHODS FOR THE PRODUCTION THEREOF
WO2024182446A3 (en) Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof
WO2022090801A3 (en) Pvrl2 and/or pvrig as biomarkers for treatment
WO2019022586A3 (ko) 간암의 예방 또는 치료용 약학적 조성물